Well JAGX is piss poor at public relations, I hope that they had all of their research in line when they started this trial. The seem to have no shortage of money, doing grants, signing up for every damn thing they can to make presentations that do not seem to pan out as far as bringing in new institutional investor and today it was a major sell of day... I hope they are not allowing insiders information that is not beneficial to investors do to a failed trial and allowing them to sell before the rest of us get that info....
I have been in a lot of biotech's and this is the first one I have seen drop as much as this has when, according to the company, results are come soon.
News 
Market Data 
Discover 
